Free Trial

Promising Dividend Stocks Worth Watching - October 3rd

Direxion Daily TSLA Bull 2X Shares logo with background

Key Points

  • The article highlights three key dividend stocks to watch: Direxion Daily TSLA Bull 2X Shares (TSLL), ProShares UltraPro Short QQQ (SQQQ), and Pfizer (PFE).
  • Direxion Daily TSLA Bull 2X Shares and ProShares UltraPro Short QQQ target high trading volumes, appealing to investors seeking steady income streams from dividends.
  • Pfizer focuses on a wide range of biopharmaceutical products, including COVID-19 treatments and vaccines, alongside other therapeutic areas such as cardiovascular and infectious diseases.
  • MarketBeat previews top five stocks to own in November.

Direxion Daily TSLA Bull 2X Shares, ProShares UltraPro Short QQQ, and Pfizer are the three Dividend stocks to watch today, according to MarketBeat's stock screener tool. Dividend stocks are shares of publicly traded companies that regularly distribute a portion of their profits to shareholders in the form of cash (or sometimes additional shares). Investors favor them when seeking a steady income stream alongside potential stock price appreciation. Common metrics for evaluating dividend stocks include the dividend yield (annual payout divided by share price) and the payout ratio (dividends as a percentage of earnings). These companies had the highest dollar trading volume of any Dividend stocks within the last several days.

Direxion Daily TSLA Bull 2X Shares (TSLL)

Read Our Latest Research Report on TSLL

ProShares UltraPro Short QQQ (SQQQ)

ProShares UltraPro Short QQQ (the Fund) seeks daily investment results, which corresponds to three times the inverse of the daily performance of the NASDAQ-100 Index (the Index). The Index includes 100 of the non-financial domestic and international issues listed on National Association of Securities Dealers Automated Quotation (NASDAQ) Stock Market.

Read Our Latest Research Report on SQQQ

Pfizer (PFE)

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands.

Read Our Latest Research Report on PFE

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Direxion Daily TSLA Bull 2X Shares Right Now?

Before you consider Direxion Daily TSLA Bull 2X Shares, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Direxion Daily TSLA Bull 2X Shares wasn't on the list.

While Direxion Daily TSLA Bull 2X Shares currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.